July 2014
An Efficient Synthesis of 3-Substituted Isoquinoline and Pyridine Derivatives by
Gold Catalyzed Intramolecular Cyclization from o-Alkynyloximes
1049
150.89, 150.70, 139.94, 137.39, 130.24, 128.70, 128.25, 126.90,
123.49, 115.62, 103.11, 55.52, 17.00. Anal. calcd. for C17H15NO:
C, 81.90; H, 6.06; N, 5.62. Found: C, 82.12; H, 5.94; N, 5.58%.
HRMS [found: m/z 249.1158 (M+), calcd for C17H15NO:
M, 249.1154].
3-Phenyl-5,6,7,8-tetrahydroisoquinoline (2l).
Colorless
1
liquid, yield (68 mg, 92%); H-NMR (400 MHz, CDCl3) δ 8.37
(s, 1H), 7.94 (d, J = 7.2 Hz, 2H), 7.46–7.35 (m, 4H), 2.79
(t, J = 4.8 Hz, 4H), 1.84 (t, J = 3.2 Hz, 4H); 13C-NMR δ 154.38,
150.23, 146.70, 139.71, 131.65, 128.58, 128.32, 126.66,
120.67, 28.94, 26.03, 22.68, 22.46. Anal. calcd. for C15H15N:
C, 86.08; H, 7.22; N, 6.69. Found: C, 85.94; H, 7.31;
N, 6.64%. HRMS [found: m/z 209.1207 (M+), calcd for
C15H15N: M, 209.1204].
3-Phenyl-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridine
(2m). Colorless liquid, yield (71 mg, 96%); 1H-NMR (400 MHz,
CDCl3) δ 8.38 (s, 1H), 7.96 (d, J = 6.8 Hz, 2H), 7.47–7.43 (m,
3H), 7.38 (t, J = 7.2 Hz, 1H), 2.82 (dd, J = 7.6 Hz, 4H), 1.89
(quintet, J = 5.6Hz, 2H), 1.69 (t, J = 4.8 Hz, 4H); 13C-NMR δ
155.61, 152.71, 149.20, 139.57, 137.26, 128.60, 128.44, 126.70,
120.76, 36.55, 32.96, 32.61, 28.04, 27.55. Anal. calcd. for
C16H17N: C, 86.05; H, 7.67; N, 6.27. Found: C, 86.12; H, 7.59;
N, 6.29%. HRMS [found: m/z 223.1358 (M+), calcd for C16H17N:
M, 223.1361].
3-Phenyl-5,6,7,8,9,10-hexahydrocycloocta[c]pyridine (2n).
Colorless liquid, yield (85 mg, 91%); 1H-NMR (400 MHz,
CDCl3) δ 8.39 (s, 1H), 7.97 (d, J = 7.6 Hz, 2H), 7.47–7.44
(m, 3H), 7.38 (t, J = 7.6 Hz, 1H), 2.79 (sextet, J = 3.6 Hz, 4H),
1.77–1.70 (m, 4H), 1.45–1.35 (m, 4H); 13C-NMR δ 155.43,
150.71, 149.78, 139.53, 135.59, 128.61, 128.43, 126.63,
120.64, 32.08, 31.74, 31.45, 29.09, 25.85, 25.50. Anal.
calcd. for C17H19N: C, 86.03; H, 8.07; N, 5.90. Found: C,
86.11; H, 8.14; N, 5.85%. HRMS [found: m/z 237.1520
(M+), calcd for C17H19N: 237.1517].
6-Chloro-3-phenylisoquinoline (2f). White solid, yield
1
(90 mg, 96%), mp. 130–131°C; H-NMR (400 MHz, CDCl3) δ
9.29 (s, 1H), 8.11 (d, J = 7.2 Hz, 2H), 7.93 (s, 1H), 8.04
(d, J = 7.8 Hz, 1H), 7.75 (d, J = 7.8 Hz, 1H), 7.84 (s, 1H), 7.52
(t, J = 7.4 Hz, 2H), 7.44 (t, J = 7.1 Hz, 1H); 13C-NMR δ 152.25,
151.12, 138.54, 136.70, 131.36, 128.94, 128.50, 127.71,
127.49, 127.07, 126.77, 126.61, 116.58. Anal. calcd. for
C15H10ClN: C, 75.16; H, 4.21; N, 5.84. Found: C, 75.24;
H, 4.14; N, 5.91%. HRMS [found: m/z 239.0506 (M+),
calcd for C15H10ClN: M, 239.0502].
6-Nitro-3-phenylisoquinoline (2g). White solid, yield (84 mg,
90%), mp. 140–141°C; 1H-NMR (400 MHz, CDCl3) δ 9.39
(s, 1H), 8.12 (d, J = 7.2 Hz, 2H), 8.33 (s, 1H), 8.18
(d, J = 7.8 Hz, 1H), 8.25 (d, J = 7.8 Hz, 1H), 7.93 (s, 1H), 7.53
(t, J = 7.4 Hz, 2H), 7.45 (t, J = 7.1 Hz, 1H); 13C-NMR δ
152.45, 151.42, 138.56, 134.70, 150.36, 128.92, 129.50,
121.71, 127.51, 127.11, 124.75, 129.67, 120.42. Anal. calcd.
for C15H10N2O2: C, 71.99; H, 4.03; N, 11.19. Found: C,
72.27; H, 4.12; N, 11.15%. HRMS [found: m/z 250.0745
(M+), calcd for C15H10N2O2: M, 250.0742].
3-Butylisoquinoline (2h).
Colorless liquid, yield (56 mg,
61%); 1H-NMR (400 MHz, CDCl3) δ 9.21 (s, 1H), 7.92
(d, J = 8.4 Hz 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.64 (t, J = 7.6 Hz,
1H), 7.52 (t, J = 8.0 Hz, 1H), 7.47 (s, 1H), 2.94 (t, J = 7.2 Hz,
2H), 1.80 (quintet, J = 7.6 Hz, 2H), 1.42 (sextet, J = 7.2 Hz, 2H),
0.96 (t, J = 7.6 Hz, 3H); 13C-NMR δ 155.87, 152.00, 136.51,
130.17, 127.48, 126.24, 126.06, 118.05, 117.89, 37.84, 32.13,
22.47, 13.97. Anal. calcd. for C13H15N: C, 84.28; H, 8.16;
N, 7.56. Found: C, 84.39; H, 8.05; N, 7.61%. HRMS [found:
m/z 185.1207 (M+), calcd for C13H15N: M, 185.1204].
REFERENCES AND NOTES
[1] Zeni, G.; Larock, R. C. Chem Rev 2006, 106, 4644.
[2] Katritzky, A. R.; Rachwal, S. Chem Rev 2010, 110, 1564.
[3] Roy, S.; Neuenswander, B.; Hill, D.; Larock, R. C. J Comb
Chem 2009, 11, 1061 and references cited therein.
[4] Ye, S.; Wang, H.; Wu, J. Eur J Org Chem 2010, 6436.
[5] Ye, S.; Wang, H.; Wu, J. ACS Comb Sci 2011, 13, 120.
[6] Chen, Z.; Yu, X.; Su, M.; Yang, X.; Wu, J. Adv Synth Catal
2009, 351, 2702.
[7] Trotter, B. W.; Nanda, K. K.; Kett, N. R.; Regan, C. P.;
Lynch, J. J.; Stump, G. L.; Kiss, L.; Wang, J.; Spencer, R. H.; Kane, S. A.;
White, R. B.; Zhang, R.; Anderson, K. D.;Liverton, N. J.; McIntyre, C. J.;
Beshore, D. C.; Hartman, G. D.; Dinsmore, C. J. J Med Chem 2006,
49, 6954.
[8] Kaneda, T.; Takeuchi, Y.; Matsui, H.; Shimizu, K.; Urakawa,
N.; Nakajyo, S. J Pharmacol Sci 2005, 98, 275.
[9] Christophe, M.; Smitha, A.; Kohn, K. W.; Cushman, M.;
Ioanoviciu, A.; Staker, B. L.; Burgin, A. B.; Stewart, L.; Pommier Y. Mol
Cancer Ther 2006, 5, 287.
[10] Kletsas, D.; Li, W.; Han, Z.; Papadopoulos, V. Biochem
Pharmacol 2004, 67, 1927.
[11] Mach, U. R.; Hackling, A. E.; Perachon, S.; Ferry, S.;
Wermuth, C. G.; Schwartz, J. C.; Sokoloff, P.; Stark, H. ChemBioChem
2004, 5, 508.
7-Phenyl-1,6-naphthyridine (2i). White solid, yield (85 mg,
91%), mp. 131–132°C; 1H-NMR (400 MHz, CDCl3) δ 9.36
(s, 1H), 9.10 (dd, J = 1.6 Hz, 1H), 8.35 (s, 1H), 8.31
(d, J = 8.0 Hz, 1H), 8.18 (d, J = 7.6 Hz, 2H), 7.56–7.50 (m, 3H),
7.45 (t, J = 6.8 Hz, 1H); 13C-NMR δ 155.92, 155.74, 153.36,
152.08, 139.55, 136.29, 129.86, 129.61, 127.90, 123.37,
122.88, 118.50. Anal. calcd. for C14H10N2: C, 81.53; H, 4.89;
N, 13.58. Found: C, 81.64; H, 4.82; N, 13.64%. HRMS [found:
m/z 206.0841 (M+), calcd for C14H10N2: M, 206.0844].
7-Phenyl-[1,3]dioxolo[4,5-g]isoquinoline (2j). Yellow solid,
yield (84mg, 89%), mp. 117–118°C, 1H-NMR (400 MHz,
CDCl3) δ 9.08 (s, 1H), 8.06 (d, J = 7.6 Hz, 2H), 7.90 (s, 1H), 7.49
(t, J = 7.6Hz, 2H), 7.40 (t, J = 7.2 Hz, 1H), 7.21 (s, 1H), 7.12
(s, 1H), 6.10 (s, 2H); 13C-NMR δ 151.15, 150.60, 150.13, 148.37,
139.62, 135.11, 128.72, 128.30, 126.82, 125.03, 116.44, 103.13,
102.80, 101.62. Anal. calcd. for C16H11NO2: C, 77.10; H, 4.45;
N, 5.62. Found: C, 77.16; H, 4.39; N, 5.64%. HRMS [found: m/z
249.0793 (M+), calcd for C16H11NO2: M, 249.0790].
3-Phenyl-6,7-dihydro-5H-cyclopenta[c]pyridine (2k). Colorless
liquid, yield (89 mg, 96%); 1H-NMR (400 MHz, CDCl3) δ 8.53 (s,
1H), 7.95 (d, J =7.6 Hz, 2H), 7.60 (s, 1H), 7.45 (t, J = 7.2 Hz, 2H),
7.38 (t, J = 7.6 Hz, 1H), 2.97 (t, J = 8.0Hz, 4H), 2.14 (quintet,
J = 7.6Hz, 2H); 13C-NMR δ 155.41, 154.60, 145.34, 139.98,
138.71, 128.59, 128.36, 126.87, 116.81, 32.71, 29.98, 25.07.
Anal. calcd. for C14H13N: C, 86.12; H, 6.71; N, 7.17. Found: C,
85.98; H, 6.89; N, 7.12%. HRMS [found: m/z 195.1052 (M+),
calcd for C14H13N: M, 195.1048].
[12] Henry, G. D. Tetrahedron 2004, 60, 6043.
[13] Timari, G.; Soos, T.; Hajos, G.; Messmer, A.; Nacsa, J.;
Molnar, J. Bioorg Med Chem Lett 1996, 23, 2831.
[14] Bentley, K. W. Nat Prod Rep 2005, 22, 249.
[15] Sotomayor, N.; Dominguez, E.; Lete, E. J Org Chem 1996,
61, 4062.
[16] Chrzanowska, M.; Rozwadowska, M. D. Chem Rev 2004,
4, 3341.
[17] Gao, H.; Zhang, J. Adv Synth Catal 2009, 351, 85.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet